Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

402 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Antithrombotic effect of two low molecular weight thrombin inhibitors and a low-molecular weight heparin in a caval vein thrombosis model in the rat.
Eriksson BI, Carlsson S, Halvarsson M, Risberg B, Mattsson C. Eriksson BI, et al. Among authors: risberg b. Thromb Haemost. 1997 Nov;78(5):1404-7. Thromb Haemost. 1997. PMID: 9408027
Prospective randomized study comparing ultrasound-guided thrombin injection to compression in the treatment of femoral pseudoaneurysms.
Lönn L, Olmarker A, Geterud K, Risberg B. Lönn L, et al. Among authors: risberg b. J Endovasc Ther. 2004 Oct;11(5):570-6. doi: 10.1583/03-1181.1. J Endovasc Ther. 2004. PMID: 15482031 Clinical Trial.
Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.
Eriksson BI, Kälebo P, Risberg B. Eriksson BI, et al. Among authors: risberg b. Semin Thromb Hemost. 1993;19 Suppl 1:122-7. Semin Thromb Hemost. 1993. PMID: 8395714 Clinical Trial. No abstract available.
Changes of plasma coagulation and fibrinolysis in response to mental stress.
Jern C, Eriksson E, Tengborn L, Risberg B, Wadenvik H, Jern S. Jern C, et al. Among authors: risberg b. Thromb Haemost. 1989 Sep 29;62(2):767-71. Thromb Haemost. 1989. PMID: 2814924
Thrombin signal transduction of the fibrinolytic system in human adult venous endothelium in vitro.
Rydholm HE, Falk P, Eriksson E, Risberg B. Rydholm HE, et al. Among authors: risberg b. Scand J Clin Lab Invest. 1998 Jul;58(4):347-52. doi: 10.1080/00365519850186535. Scand J Clin Lab Invest. 1998. PMID: 9741823
Plasminogen activators and inhibitors in peritoneal tissue.
Holmdahl L, Falkenberg M, Ivarsson ML, Risberg B. Holmdahl L, et al. Among authors: risberg b. APMIS. 1997 Jan;105(1):25-30. doi: 10.1111/j.1699-0463.1997.tb00535.x. APMIS. 1997. PMID: 9063497
Different fibrinolytic potentials between human umbilical vein endothelial cells and human adult vein endothelial cells.
Rydholm H, Boström S, Eriksson E, Risberg B. Rydholm H, et al. Among authors: risberg b. Eur Surg Res. 1996;28(5):380-7. doi: 10.1159/000129480. Eur Surg Res. 1996. PMID: 8880128
Expression of plasminogen activator inhibitor-1 mRNA in healthy, atherosclerotic and thrombotic human arteries and veins.
Arnman V, Nilsson A, Stemme S, Risberg B, Rymo L. Arnman V, et al. Among authors: risberg b. Thromb Res. 1994 Dec 1;76(5):487-99. doi: 10.1016/0049-3848(95)90180-n. Thromb Res. 1994. PMID: 7900096
Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay.
Eriksson E, Rånby M, Gyzander E, Risberg B. Eriksson E, et al. Among authors: risberg b. Thromb Res. 1988 Apr 1;50(1):91-101. doi: 10.1016/0049-3848(88)90177-6. Thromb Res. 1988. PMID: 3135638
Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin.
Eriksson E, Wollter IM, Christenson B, Stigendal L, Risberg B. Eriksson E, et al. Among authors: risberg b. Thromb Haemost. 1988 Apr 8;59(2):284-8. Thromb Haemost. 1988. PMID: 2838926 Clinical Trial.
402 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback